Alnylam Pharmaceuticals, Inc.
2013 Q4 - 2025 Q4 (26 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/28/2026 | 7,967 | 0.0% | 20,035 | 12/31/2025 |
| 2025 Q3 | 10/30/2025 | 15,341 | 0.1% | 33,642 | 9/30/2025 |
| 2025 Q2 | 8/1/2025 | 11,872 | 0.0% | 36,408 | 6/30/2025 |
| 2025 Q1 | 4/28/2025 | 9,528 | 0.0% | 35,285 | 3/31/2025 |
| 2024 Q4 | 2/11/2025 | 9,195 | 0.0% | 39,075 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 9,255 | 0.0% | 33,650 | 9/30/2024 |
| 2024 Q2 | 8/9/2024 | 7,136 | 0.0% | 29,365 | 6/30/2024 |
| 2024 Q1 | 5/6/2024 | 4,264 | 0.0% | 28,533 | 3/31/2024 |
| 2023 Q4 | 2/7/2024 | 5,592 | 0.0% | 29,214 | 12/31/2023 |
| 2023 Q3 | 10/31/2023 | 5,837 | 0.0% | 32,958 | 9/30/2023 |
| 2023 Q2 | 7/19/2023 | 6,129 | 0.0% | 32,266 | 6/30/2023 |
| 2023 Q1 | 5/12/2023 | 5,767 | 0.0% | 28,787 | 3/31/2023 |
| 2022 Q4 | 2/13/2023 | 3,176 | 0.0% | 13,365 | 12/31/2022 |
| 2022 Q3 | 11/3/2022 | 3,478 | 0.0% | 17,374 | 9/30/2022 |
| 2022 Q2 | 8/9/2022 | 2,688 | 0.0% | 18,428 | 6/30/2022 |
| 2022 Q1 | 5/9/2022 | 4,008 | 0.0% | 24,543 | 3/31/2022 |
| 2021 Q4 | 2/10/2022 | 3,839 | 0.0% | 22,638 | 12/31/2021 |
| 2021 Q3 | 11/9/2021 | 5,558 | 0.0% | 29,435 | 9/30/2021 |
| 2021 Q2 | 8/5/2021 | 2,562 | 0.0% | 15,116 | 6/30/2021 |
| 2021 Q1 | 5/11/2021 | 1,813 | 0.0% | 12,841 | 3/31/2021 |
| 2020 Q4 | 2/11/2021 | 1,360 | 0.0% | 10,461 | 12/31/2020 |
| 2020 Q3 | 11/2/2020 | 4,176 | 0.0% | 28,679 | 9/30/2020 |
| 2020 Q2 | 8/11/2020 | 6,934 | 0.1% | 46,818 | 6/30/2020 |
| 2014 Q2 | 8/5/2014 | 129 | 0.0% | 2,036 | 6/30/2014 |
| 2014 Q1 | 5/1/2014 | 148 | 0.0% | 2,199 | 3/31/2014 |
| 2013 Q4 | 2/5/2014 | 136 | 0.0% | 2,115 | 12/31/2013 |